Annexon Inc. (ANNX)
NASDAQ: ANNX
· Real-Time Price · USD
2.58
0.15 (6.17%)
At close: Jun 05, 2025, 1:42 PM
6.17% (1D)
| Bid | 2.58 |
| Market Cap | 283.61M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -167.38M |
| EPS (ttm) | -1.17 |
| PE Ratio (ttm) | -2.21 |
| Forward PE | -1.59 |
| Analyst | Buy |
| Ask | 2.59 |
| Volume | 2,560,040 |
| Avg. Volume (20D) | 1,738,384 |
| Open | 2.37 |
| Previous Close | 2.43 |
| Day's Range | 2.29 - 2.64 |
| 52-Week Range | 1.28 - 7.85 |
| Beta | 1.26 |
About ANNX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ANNX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ANNX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
-5.52%
Annexon shares are trading higher after the compan...
Unlock content with
Pro Subscription
5 months ago
+13.96%
Annexon shares are trading higher after the company announced topline results from a study supporting Anx005 as a potential treatment for Guillain-barré syndrome.
